9PU.F GLOBAL COSMED SA CF ZY1
- Market cap
- EUR 34.2M
- P/E
- 10.0x
- P/B
- 0.55x
- ROE
- 3.1%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 9PU.F undervalued?
Graham number9PU.F trades 50.7% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
GLOBAL COSMED SA CF ZY1 fundamental analysis
No fundamental analysis for GLOBAL COSMED SA CF ZY1 yet.
GLOBAL COSMED SA CF ZY1 stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About GLOBAL COSMED SA CF ZY1
Dr. Miele Cosmed Group S.A. produces and sells chemical and cosmetic assortments in Poland and internationally. It offers washing and care cosmetics, wet wipes, and laundry detergents for children; cleansing cosmetics, such as sanitizing gels and sprays, and liquid soaps; shower gels; and toilet cleaners, toilet blocks, and drain opener granules and gels; washing liquids and fabric softening concentrates; cleaning agents for kitchens and bathrooms; and hand sanitizing and su…
Full company profileGLOBAL COSMED SA CF ZY1 financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
GLOBAL COSMED SA CF ZY1 annual financial statements (PLN; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 352M | 397M | 444M | 488M | 504M | 482M |
| Gross Profit | 134M | 125M | 172M | 209M | 213M | 208M |
| Operating Income | 15.2M | 2.58M | 33.3M | 46.7M | 29.0M | 13.4M |
| EBITDA | - | 13.0M | 43.8M | 61.0M | 44.2M | 31.0M |
| Net Income | 11.6M | -2.27M | 22.2M | 36.0M | 19.7M | 8.59M |
| EPS | 0.13 | -0.03 | 0.26 | 0.42 | 0.23 | 0.10 |
| Balance Sheet | ||||||
| Total Assets | 362M | 374M | 382M | 405M | 426M | 443M |
| Total Liabilities | 144M | 162M | 148M | 146M | 156M | 168M |
| Shareholders' Equity | 217M | 213M | 234M | 259M | 270M | 275M |
| Cash & Short-term Investments | 11.3M | 9.30M | 14.2M | 20.4M | 11.7M | 3.70M |
| Cash Flow | ||||||
| Operating Cash Flow | 26.1M | 5.80M | 31.3M | 45.7M | 39.1M | 17.5M |
| Capital Expenditure | 17.8M | 6.55M | 9.69M | 26.6M | 26.1M | 28.2M |
| Free Cash Flow | 8.35M | -753K | 21.6M | 19.1M | 13.0M | -10.7M |
| Ratios | ||||||
| ROE | 5.3% | -1.1% | 9.5% | 13.9% | 7.3% | 3.1% |
| ROA | 3.2% | -0.6% | 5.8% | 8.9% | 4.6% | 1.9% |
| Net Profit Margin | 3.3% | -0.6% | 5.0% | 7.4% | 3.9% | 1.8% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
GLOBAL COSMED SA CF ZY1 dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- 21.8%
- Ex-dividend date
- Jul 1, 2025
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | PLN 4.29M | 0.05 | 21.8% |
| 2024 | PLN 7.84M | 0.09 | 21.8% |
| 2023 | - | - | - |
| 2022 | PLN 2.61M | 0.03 | - |
| 2021 | PLN 5.24M | 0.06 | 45.2% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns GLOBAL COSMED SA CF ZY1
- Insiders 95.21%
- Institutions 0.00%
- Public & others 4.79%
- Shares outstanding 85.8M
- Free float 4.18M
GLOBAL COSMED SA CF ZY1 company profile
- Company name
- GLOBAL COSMED SA CF ZY1
- Ticker
- 9PU.F
- ISIN
- PLGLBLC00011
- Exchange
- Frankfurt Exchange
- Sector
- Consumer Defensive
- Industry
- Personal Care Products
- Employees
- 582
- Fiscal year end
- December
- Address
- Wielkopolska 3 Street, Radom, Poland, 26-600
- Phone
- 48 48 384 5801
- Website
- dr-miele.eu
About GLOBAL COSMED SA CF ZY1
Dr. Miele Cosmed Group S.A. produces and sells chemical and cosmetic assortments in Poland and internationally. It offers washing and care cosmetics, wet wipes, and laundry detergents for children; cleansing cosmetics, such as sanitizing gels and sprays, and liquid soaps; shower gels; and toilet cleaners, toilet blocks, and drain opener granules and gels; washing liquids and fabric softening concentrates; cleaning agents for kitchens and bathrooms; and hand sanitizing and surface disinfectants. The company markets its products primarily under the Bobini, Apart, Biophen, Mole, Sofin, Izo, and Izozid brands. The company was formerly known as Global Cosmed S.A. and changed its name to Dr. Miele Cosmed Group S.A. in March 2024. The company was founded in 1990 and is based in Radom, Poland.
GLOBAL COSMED SA CF ZY1 management
2- Ms. Magdalena MieleChairman of the Management Board
- Mr. Arthur MielimonkaMember of Management Board